	US 12,064,396 B2
	Medical containers and system components with non-DEHP plasticizers for storing red blood cell products, plasma and platelets
Karin Platenkamp, Enschede (NL); Craig L. Sandford, Buffalo Grove, IL (US); and Koos L. Hakvoort, Emmen (NL)
Assigned to Fresenius Kabi Deutschland GmbH, Bad Homburg (DE)
Filed by Fresenius Kabi Deutschland GmbH, Bad Homburg (DE)
Filed on Oct. 28, 2021, as Appl. No. 17/513,565.
Application 17/513,565 is a continuation of application No. 15/118,396, granted, now 11,160,728, previously published as PCT/EP2014/078127, filed on Dec. 17, 2014.
Claims priority of application No. 14155899 (EP), filed on Feb. 20, 2014.
Prior Publication US 2022/0117844 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61J 1/14 (2023.01); A61J 1/10 (2006.01); A61J 1/18 (2023.01); A61J 1/20 (2006.01); A61M 1/02 (2006.01); C08K 5/10 (2006.01); C08K 5/11 (2006.01); C08K 5/12 (2006.01)

CPC A61J 1/1468 (2015.05) [A61J 1/10 (2013.01); A61J 1/1475 (2013.01); A61J 1/18 (2013.01); A61J 1/201 (2015.05); A61J 1/2037 (2015.05); A61J 1/2048 (2015.05); A61M 1/0209 (2013.01); C08K 5/10 (2013.01); C08K 5/11 (2013.01); C08K 5/12 (2013.01); C08K 2201/014 (2013.01); C08K 2201/019 (2013.01)]

13 Claims

1. A container for blood or a blood component, the container comprising one or more container walls defining an interior chamber, the container walls comprising one or more layers, the layers comprising a composition comprising one or more polymeric materials and a blend of two extractable agents, wherein the blend consists of about 50% to about 70% w/w of di-2-ethyl hexyl terephthalate (DEHT) and about 30% to about 50% w/w of acetyl tributyl citrate (ATBC), or about 40% to about 60% w/w of DEHT and about 60% to about 40% w/w of butiryl trihexyl citrate (BTHC), or about 40% to 60% w/w of DEHT and about 60% to about 40% w/w of a polyol ester, wherein the container further comprises one or more additional components, and wherein the container comprises less than about 3% (w/w) of phthalates, including di-2-ethylhexyl phthalate (DEHP).